002252 logo

Shanghai RAAS Blood Products Co., Ltd. Stock Price

SZSE:002252 Community·CN¥41.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002252 Share Price Performance

CN¥6.35
-0.43 (-6.34%)
CN¥6.35
-0.43 (-6.34%)
Price CN¥6.35

002252 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and fair value.

1 Risk
3 Rewards

Shanghai RAAS Blood Products Co., Ltd. Key Details

CN¥8.0b

Revenue

CN¥5.0b

Cost of Revenue

CN¥3.0b

Gross Profit

CN¥1.2b

Other Expenses

CN¥1.8b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 27, 2026
0.28
37.72%
22.96%
8.7%
View Full Analysis

About 002252

Founded
1988
Employees
3350
CEO
Jun Xu
WebsiteView website
www.raas-corp.com

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. The company was founded in 1988 and is based in Shanghai, China.

Recent 002252 News & Updates

Recent updates

No updates